Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19

Background: In November 2020, the FDA issued an emergency use authorization (EUA) for monoclonal antibodies (mAbs) to be used in outpatients with COVID-19 infections who are at a high risk of progressing to severe disease. However, becuase the EUA had limited indications for inpatients, data on thei...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam Zimilover (Author), Thien-Ly Doan (Author), Sumeet Jain (Author), Prashant Malhotra (Author)
Format: Book
Published: Cambridge University Press, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available